OTCPK:BRRZ.Y

Stock Analysis Report

Executive Summary

Total Brain Limited, through its subsidiaries, engages in developing and commercializing brain health products in Australia and the United States.

Snowflake

Fundamentals

High growth potential with adequate balance sheet.

Risks

  • Total Brain has significant price volatility in the past 3 months.
  • Total Brain is covered by less than 3 analysts.

Share Price & News

How has Total Brain's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

BRRZ.Y

-0.04%

US Healthcare

-0.6%

US Market


1 Year Return

n/a

BRRZ.Y

-9.1%

US Healthcare

0.6%

US Market

No trading data on BRRZ.Y.

No trading data on BRRZ.Y.


Share holder returns

BRRZ.YIndustryMarket
7 Day0%-0.04%-0.6%
30 Day0%-0.5%2.2%
90 Day0%-1.6%1.1%
1 Yearn/a-7.7%-9.1%2.9%0.6%
3 Yearn/a29.6%24.3%44.6%35.2%
5 Year-96.7%-96.7%66.1%56.2%61.9%44.2%

Price Volatility Vs. Market

How volatile is Total Brain's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Total Brain undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Total Brain's share price is below the future cash flow value, and at a moderate discount (> 20%).

Total Brain's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

Total Brain is loss making, we can't compare its value to the US Healthcare industry average.

Total Brain is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Total Brain, we can't assess if its growth is good value.


Price Based on Value of Assets

Total Brain is good value based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is Total Brain expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

97.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Total Brain's revenue is expected to grow significantly at over 20% yearly.

Total Brain's earnings are expected to grow significantly at over 20% yearly.

Total Brain's revenue growth is expected to exceed the United States of America market average.

Total Brain's earnings growth is expected to exceed the United States of America market average.

Total Brain's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Total Brain is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Total Brain performed over the past 5 years?

-38.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Total Brain does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Total Brain's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Total Brain's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Total Brain has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Total Brain has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Total Brain improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Total Brain's financial position?


Financial Position Analysis

Total Brain is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Total Brain's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Total Brain has no debt.

Total Brain has no debt compared to 5 years ago when it was 57.1%.


Balance Sheet

Low level of unsold assets.

Total Brain has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Total Brain has less than a year of cash runway based on current free cash flow.

Total Brain has less than a year of cash runway if free cash flow continues to grow at historical rates of 37.9% each year.


Next Steps

Dividend

What is Total Brain's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Total Brain's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Total Brain's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Total Brain has not reported any payouts.

Unable to verify if Total Brain's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Total Brain has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Total Brain's salary, the management and board of directors tenure and is there insider trading?

2.1yrs

Average management tenure


CEO

Louis Gagnon 0

2.3yrs

Tenure

AU$662,443

Compensation

Mr. Louis Gagnon has been Chief Executive Officer of Brain Resource Limited since May 22, 2017 and has been its Managing Director since December 22, 2017. Mr. Gagnon served as Chief Product and Marketing O ...


CEO Compensation Analysis

Louis's remuneration is about average for companies of similar size in United States of America.

Louis's compensation has increased whilst company is loss making.


Management Age and Tenure

2.1yrs

Average Tenure

The tenure for the Total Brain management team is about average.


Board Age and Tenure

1.5yrs

Average Tenure

The average tenure for the Total Brain board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Dan Segal

    Consultant

    • Tenure: 2.9yrs
    • Compensation: AU$238.40k
  • Evian Gordon

    Founder & Executive Chairman

    • Tenure: 0yrs
    • Compensation: AU$537.36k
  • Marcel Legrand

    Head of Revenue & Corporate Development

    • Tenure: 2.1yrs
  • Phillip Hains

    Joint Company Secretary

    • Tenure: 1.2yrs
  • Louis Gagnon

    MD, CEO & Director

    • Tenure: 2.3yrs
    • Compensation: AU$662.44k
  • Matt Mund

    Chief Operating Officer

    • Tenure: 2.1yrs
    • Compensation: AU$412.12k
  • Emil Vasilev

    Director of Finance & Operations

    • Tenure: 2.3yrs
    • Compensation: AU$298.94k
  • Matt Resteghini

    Chief Marketing Officer

    • Tenure: 1.6yrs
  • Harvey Bui

    Joint Company Secretary

    • Tenure: 1.2yrs

Board Members

  • Evian Gordon

    Founder & Executive Chairman

    • Tenure: 0yrs
    • Compensation: AU$537.36k
  • Matt Morgan (45yo)

    Non-Executive Director

    • Tenure: 3.5yrs
    • Compensation: AU$283.40k
  • Louis Gagnon

    MD, CEO & Director

    • Tenure: 2.3yrs
    • Compensation: AU$662.44k
  • Ajay Arora

    Non-Executive Director

    • Tenure: 1.3yrs
  • David Torrible

    Non-Executive Director

    • Tenure: 0.3yrs

Company Information

Total Brain Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Total Brain Limited
  • Ticker: BRRZ.Y
  • Exchange: OTCPK
  • Founded: 2000
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: AU$27.997m
  • Listing Market Cap: AU$18.851m
  • Shares outstanding: 777.69m
  • Website: https://www.totalbrain.com

Number of Employees


Location

  • Total Brain Limited
  • 268 Bush Street
  • Suite 2633
  • San Francisco
  • California
  • 94104
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TTBASX (Australian Securities Exchange)YesOrdinary SharesAUAUDAug 2001
BRRZ.YOTCPK (Pink Sheets LLC)SPONSORED ADSUSUSDApr 2011

Biography

Total Brain Limited, through its subsidiaries, engages in developing and commercializing brain health products in Australia and the United States. The company’s products include Total Brain, a brain health ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/02 00:16
End of Day Share Price2019/06/04 00:00
Earnings2019/06/30
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.